Shorter radiation for breast cancer shows promise in small trial
NCT ID NCT04913532
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a shorter course of radiation therapy for people with early-stage breast cancer after lumpectomy. The goal was to see if this approach causes fewer skin side effects. 35 participants received the treatment, and researchers measured how many developed moderate to severe skin reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hypofractionated radiation with simultaneous integrated boost
What this could lead to
If successful, this could offer a shorter, more convenient radiation course for early breast cancer with fewer skin side effects.
What could go wrong
This is a small, single-group trial with only 35 participants, so results may not apply to everyone. It only looked at short-term side effects, not long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Shijitan Hospital
Beijing, 100038, China